Skip to main content

Independent service, not a government website.

Federal grantOpenGrant opportunity

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Department of Health and Human Services, National Institutes of Health

Grant details

Application deadline
Jan 7, 2028
Posted
Nov 6, 2024
Funding opportunity number
PAR-25-175
Grants.gov ID
357003
Funding instrument
Grant
Category of funding
Education, Health
Opportunity category
Discretionary
Award ceiling
$500,000
Award floor
Not stated
Total program funding
$500,000
Expected awards
Not stated
Cost sharing required
No
Assistance Listing (ALN/CFDA)
  • 93.393 — Cancer Cause and Prevention Research
  • 93.394 — Cancer Detection and Diagnosis Research
  • 93.395 — Cancer Treatment Research
Archive date
Feb 12, 2028

Who can apply

Businesses are among the eligible applicants listed on Grants.gov.

  • State governments
  • Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
  • City or township governments
  • Public housing authorities/Indian housing authorities
  • County governments
  • Special district governments
  • Private institutions of higher education
  • Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
  • Native American tribal organizations (other than Federally recognized tribal governments)
  • Others (see text field entitled "Additional Information on Eligibility" for clarification)
  • Public and State controlled institutions of higher education
  • Independent school districts
  • Small businesses
  • Native American tribal governments (Federally recognized)
  • For profit organizations other than small businesses

Additional information on eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.

Description

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Announcement and documents

Grantor contact

No contacts listed in the notice data.

As published on the Grants.gov listing. This office in the buyer directory (paid plans and match reports).

Grants: Grants.gov (federal grant opportunities) · last updated Nov 20, 2026, 4:20 PM ET.

This product uses the Grants.gov API but is not endorsed or certified by the U.S. Department of Health and Human Services.

Always confirm details, amendments and deadlines on the official listing. Government Bid Finder is an independent service and is not affiliated with or endorsed by the U.S. government.